A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MPA / monocyte-platelet aggregates

[Related PubMed/MEDLINE]
Total Number of Papers: 37
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MPA  (>> Co-occurring Abbreviation)
Long Form:   monocyte-platelet aggregates
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Increased monocyte-platelet aggregates and monocyte-endothelial adhesion in healthy individuals with vitamin D deficiency. VDR, VitD-Def
2020 Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban. AF, OAC, TGT
2019 Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease. CVD, PAD
2019 Monocyte-platelet aggregates affect local inflammation in patients with acute myocardial infarction. AMI
2019 Predicting significance of COX-2 expression of peripheral blood monocyte in patients with coronary artery disease. CAD, CI, COX-2, hs-CRP, MCP-1, OR, RT-PCR, SA, UA, WBC
2018 Decreased platelet inhibition by P2Y12 receptor blockers in anaemia. ADP, LTA
2018 Multiplexed Label-Free Fractionation of Peripheral Blood Mononuclear Cells for Identification of Monocyte-Platelet Aggregates. MACS, PBMCs, T2DM
2017 Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis. GP, PAR, VTE
2017 The influence of different anticoagulants and time-delayed sample processing and measurements on human monocyte subset and monocyte-platelet aggregate analyses. EDTA, FCM, SC
10  2016 Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures. ADP, CA, RIPC
11  2016 Impact of commonly prescribed exercise interventions on platelet activation in physically inactive and overweight men. ---
12  2016 In Vivo and protease-activated receptor-1-mediated platelet activation in patients presenting for cardiac catheterization. ACS, TRAP
13  2016 Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis. AUC, PF, sCD40L, sP-selectin, TSP
14  2016 PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis. GP, HR, PAR, VTE
15  2016 The Antiplatelet Effect of Clopidogrel Decreases With Patient Age. ADP, GP
16  2016 The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events. MI, PCI, STEMI
17  2015 Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation. ADMA, IL
18  2014 Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease. CAD, HBDs
19  2014 Monocyte-platelets aggregates as cellular biomarker of endothelium-dependent coronary vasomotor dysfunction in patients with coronary artery disease. CVF, FFR
20  2014 Outer membrane vesicles alter inflammation and coagulation mediators. HUVECs, OMVs, TF
21  2014 Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker. ARB, EH, NT, UH
22  2014 Platelet activation increases in patients undergoing vascular surgery. ADP
23  2014 Platelets induce a proinflammatory phenotype in monocytes via the CD147 pathway in rheumatoid arthritis. MMP-9, NF-kappaB, RA
24  2014 Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty. AA, ADP, CAD, MEA, PAD, TRAP
25  2013 Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel. GP, TRAP
26  2013 Preserved thrombin-inducible platelet activation in thienopyridine-treated patients. ADP, HRPR, MEA, TRAP, VASP
27  2012 Impact of exercise training on inflammation and platelet activation in patients with intermittent claudication. BMT, hs-CRP, IL-6, PAD, SET, sP-sel
28  2011 Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. COX, PSGL-1
29  2011 Platelet activation in chronic cocaine users: effect of short term abstinence. NAP-2, RANTES, sCD40L
30  2011 Platelet reactivity and endothelial function in children of patients with early acute myocardial infarction. ADP, AMI, EST, FMD
31  2011 Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction. CAD, MNC, MoTF, TF
32  2010 Brief low-workload myocardial ischaemia induces protection against exercise-related increase of platelet reactivity in patients with coronary artery disease. EST
33  2009 Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. BP, NO, NT, SBP, SNO, UH
34  2009 The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity. AA
35  2007 Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates. NO, sGC
36  2005 GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. ELISA, LPA, PCI, sCD40L
37  2001 Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. AMI, CI, ED